Ivan Wilmot Selected Research

Ivan Wilmot Research Topics

2	Disease Progression 11/2023 - 10/2021
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 11/2023 - 10/2021
2	Myocarditis (Carditis) 06/2011 - 01/2011
1	Restrictive Cardiomyopathy 02/2015
1	Hemorrhagic Stroke 02/2015
1	Lymphadenopathy 02/2015
1	Castleman Disease (Castleman's Disease) 02/2015
1	Heart Arrest (Cardiac Arrest) 02/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2015
1	Cardiomyopathies (Cardiomyopathy) 01/2015
1	Congenital Heart Defects (Congenital Heart Defect) 01/2015
1	Heart Failure 12/2013
1	Pathologic Dilatation (Ectasia) 01/2011
1	Vasculitis (Vasculitides) 01/2011
1	Ulcerative Colitis 01/2011
1	Chest Pain (Chest Pains) 01/2011
1	Pediatric ulcerative colitis 01/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2005

2	Valsartan (Vals)FDA Link 11/2023 - 10/2021
1	dimemorfan (AT 17)IBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 02/2015
1	TroponinIBA 01/2011
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2011
1	Muromonab-CD3 (Muromonab CD3)FDA Link 11/2005

5	Therapeutics 11/2023 - 01/2011
2	Extracorporeal Membrane Oxygenation 01/2015 - 06/2011
2	Transplantation 12/2013 - 06/2011
1	Drug Therapy (Chemotherapy) 02/2015
1	Artificial Respiration (Mechanical Ventilation) 01/2015
1	Heart-Assist Devices 06/2011